Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

• Autores principales: Cristóbal Morales (Autor), Juan Francisco Merino-Torres (Autor), Paloma Moreno-Moreno (Autor), María Lainez (Autor), Iñigo Tejado (Autor), Alfredo Yoldi (Autor), Sonsoles Gutiérrez Medina (Autor), Alfonso Soto (Autor), Manuel A Botana (Autor), Virginia Bellido (Autor), Irene Caballero (Autor)
• Formato: Libro
• Publicado: BioExcel Publishing Ltd, 2022-02-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: This study aims to evaluate dapagliflozin in patients with type 2 diabetes (T2D) in clinical practice in Spain. Methods: This is a retrospective study including adults with T2D under stable antidiabetic therapy, with either dapagliflozin or sitagliptin ≥6 months, before inclusion. Data a...